|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.43 CAD | 0.00% |
|
-1.15% | -12.24% |
| Mar. 13 | Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share | MT |
| Mar. 13 | Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023. | CI |
Crescita Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CAD 4.6 million compared to CAD 4.95 million a year ago. Net loss was CAD 0.273 million compared to CAD 0.474 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.24% | 6.12M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
CRESCITA THERAPEUTICS INC. 
